Chris A. Rallis, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 13,592 shares at $8.17 ($111K) on 2023-07-24, disclosed to the SEC on 2023-07-24.
Scheduled sale ($111k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.17 | 6,796 | $56K | 50.0% |
| 2 | $8.17 | 6,796 | $56K | 50.0% |
| Total | $8.17 avg | 13,592 | $111K | 100% |
| Filing → |
| FENC | SELL | 2025-07-07 | $10K | — | Filing → |
| FENC | SELL | 2025-04-11 | $7K | — | Filing → |
| FENC | SELL | 2025-02-14 | $8K | — | Filing → |